Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Fibryga® (fibrinogen [human]) – New indication
July 31, 2024 - The FDA approved Octapharma’s Fibryga (fibrinogen [human]), for fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency.
